Sector consensus Alkem Laboratories Limited Bombay S.E.

Stocks

Delayed Bombay S.E. 09:31:44 23/09/2026 BST			5-day change	1st Jan Change
5,409.15 ^INR	+1.35%		+4.24%	-1.75%

09-16	Alkem Laboratories Limited Launches Neuceno for the Treatment of Partial-Onset Seizures in Adult Patients	CI
09-15	Alkem Laboratories Limited Announces Appointment of Shubhadeep Sinha to Senior Management Position, Effective September 15, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Average Target P.	Objective/dr gap	Nbr of analysts
ELI LILLY AND COMPANY		1,325.39	+13.27%	29
JOHNSON & JOHNSON		277.91	+3.24%	22
ABBVIE INC.		278.61	+5.05%	28
ROCHE HOLDING AG		375.34	+3.09%	19
NOVARTIS AG		152.43	+7.5%	22
ASTRAZENECA PLC	-	211.41	+25.05%	23
AMGEN INC.		385.21	-6.1%	28
GILEAD SCIENCES, INC.		158.15	+3.59%	27
NOVO NORDISK A/S		307.56	+18.84%	23
PFIZER INC.		28.88	+3.38%	26
VERTEX PHARMACEUTICALS INCORPORATED		570.07	+10.7%	28
BRISTOL-MYERS SQUIBB COMPANY		66.71	+7.16%	24
SANOFI		94.06	+26.44%	24
GSK PLC		21.71	+13.9%	21
CHUGAI PHARMACEUTICAL CO., LTD.		9,323.33	+38.21%	15
TAKEDA PHARMACEUTICAL COMPANY LIMITED		6,622.06	+10.96%	16
BAYER AG		58.22	+17.5%	18
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD		71.35	+56.07%	17
Average		1,129.36	+14.32%	23
Weighted average by Cap.		725.97	+9.91%	25